Healwell AI (TSE:AID – Get Free Report) was upgraded by equities researchers at Canaccord Genuity Group to a “moderate buy” rating in a note issued to investors on Tuesday,Zacks.com reports.
Separately, TD Securities raised shares of Healwell AI to a “strong-buy” rating in a research note on Thursday, April 2nd. One investment analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Strong Buy”.
Check Out Our Latest Stock Report on Healwell AI
Healwell AI Price Performance
See Also
- Five stocks we like better than Healwell AI
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for Healwell AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healwell AI and related companies with MarketBeat.com's FREE daily email newsletter.
